Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000803012-25-000036
Filing Date
2025-11-14
Accepted
2025-11-14 11:10:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 13638
  Complete submission text file 0000803012-25-000036.txt   15790
Mailing Address ONE VANDERBILT AVENUE NEW YORK NY 10017
Business Address ONE VANDERBILT AVENUE NEW YORK NY 10017 212-827-6971
TD SECURITIES (USA) LLC (Filed by) CIK: 0000803012 (see all company filings)

EIN.: 581495511 | State of Incorp.: DE | Fiscal Year End: 1031
Type: SCHEDULE 13G/A

Mailing Address TRIDENT COURT, 1 OAKCROFT ROAD CHESSINGTON SURREY X0 KT9 1BD
Business Address TRIDENT COURT, 1 OAKCROFT ROAD CHESSINGTON SURREY X0 KT9 1BD 011-44-208-090-2009
OneMedNet Corp (Subject) CIK: 0001849380 (see all company filings)

EIN.: 862076743 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92531 | Film No.: 251482797
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)